Capital Impact Advisors’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-65,147	Closed	-$606K	–	7
2024 Q2	$606K	Buy	+65,147	New	+$606K	1.71%	37